Searched for
DIABETES TREATMENT COMPLICATIONS
A new nanotech breakthrough could help heal dangerous wounds antibiotics can’t treatScientists are using nanomaterials to heal stubborn wounds that resist antibiotic treatment through a new era of smart wound care. These li...- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
- PCOS now PMOS: Health condition that affects every eighth woman renamed after 14 years of misunderstandingPolycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its systemic impact bey...
- For investors with patience, experience, and anxiety appetite: 5 stocks from different sectors with upside potential of up to 21%For the last five years, the theme on the street has mostly been: Buy today, expect comfort tomorrow. But some of the better wealth-creatin...
- Health Ministry releases guidance document on Childhood Diabetes at National SummitThe Guidance Document establishes, for the first time, a structured and standardised national framework for the screening, diagnosis, treat...
- Deadly ‘flesh-eating’ bacteria with 20% mortality risk detected in Long Island: Symptoms, spread, treatment and preventionScientists have detected the potentially deadly "flesh-eating" bacteria, Vibrio vulnificus, in Long Island waters, posing a significant ris...
- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
- US Stocks: Kodiak Sciences shares soar 68% after eye drug succeeds in late-stage studyShares of Kodiak Sciences surged 68.6% to their highest in more than four years on Thursday after the drug developer's experimental drug me...
- Managing diabetes early: A smart choice to considerEarly management of type 2 diabetes is crucial in India, where the disease poses a significant health and financial burden. Starting treatm...
- A comprehensive approach to diabetes careIndia faces a significant diabetes challenge, with high prevalence, underdiagnosis, and poor control contributing to early complications an...
- India has the highest number of diabetic people in the world, even more than China: ReportA new study reveals that over 800 million adults worldwide have diabetes. India leads the world with 212 million cases, followed by China w...
- The ‘C’ and ‘D’ of diabetesEarly control of HbA1c levels and weight in people with diabetes significantly reduces cardiac disease risk. Delays in treatment heighten c...
- The ‘A’ and ‘B’ of diabetes: When less is moreHbA1c testing is crucial for diabetes management as it reflects average blood sugar levels over three months, unlike single-point fasting o...
- Amid rise in COVID cases, ICMR issues guidelines for management of type 1 diabetesThe guidelines have mentioned about the burden of diabetes increased among the young population in India, type 1 diabetes is commonest in c...
- How much weight you should lose to keep your diabetes under control? Here is the answer"Treatment of obesity to achieve a sustained loss of 15 per cent body weight has been shown to have a major impact on type 2 diabetes progr...
- People suffering from diabetic eye disease five times more likely to get severe CovidDiabetics are at high risk of vascular complications affecting the large and small blood vessels.
- New diabetes drug cuts cost by 80%A completely new drug in the 'gliptin' family has disrupted the anti-diabetes market by lowering the cost of therapy for patients by 80%.
- US clamps down on sale of 'natural' diabetes drugs from IndiaUS health regulator FDA has initiated action against 15 companies for supply of illegal sale of India-originating drugs.
- India and US sign agreement on collaboration in Diabetes researchThe primary aim of this collaboration is to initiate a health research relationship between the two countries.
Load More
